Adipose tissue-selective ablation of ADAM10 results in divergent metabolic phenotypes following long-term dietary manipulation

References

• Andersson ER, Sandberg R, Lendahl U. Notch signaling: simplicity in design, versatility in function. Development. 2011;138(17):3593–12. doi: 10.1242/dev.063610
   PubMed Web of Science ®Google Scholar
• Bi P, Kuang S. Notch signaling as a novel regulator of metabolism. Trends Endocrinol Metab. 2015;26(5):248–255. doi: 10.1016/j.tem.2015.02.006
   PubMed Web of Science ®Google Scholar
• Guruharsha KG, Kankel MW, Artavanis-Tsakonas S. The notch signalling system: recent insights into the complexity of a conserved pathway. Nat Rev Genet. 2012;13(9):654–666. doi: 10.1038/nrg3272
   PubMed Web of Science ®Google Scholar
• Kopan R, Ilagan MX. The canonical notch signaling pathway: unfolding the activation mechanism. Cell. 2009;137(2):216–233. doi: 10.1016/j.cell.2009.03.045
   PubMed Web of Science ®Google Scholar
• Wetzel S, Seipold L, Saftig P. The metalloproteinase ADAM10: A useful therapeutic target?. Biochim Biophys Acta, Mol Cell Res. 2017;1864(11 Pt B):2071–2081. doi: 10.1016/j.bbamcr.2017.06.005
   PubMed Web of Science ®Google Scholar
• Seegar TCM, Killingsworth LB, Saha N, et al. Structural basis for regulated proteolysis by the alpha-secretase ADAM10. Cell. 2017;171(7):1638–48 e7. doi: 10.1016/j.cell.2017.11.014
   PubMed Web of Science ®Google Scholar
• Fukuda D, Aikawa E, Swirski FK, et al. Notch ligand delta-like 4 blockade attenuates atherosclerosis and metabolic disorders. Proc Natl Acad Sci USA. 2012;109(27):E1868–77. doi: 10.1073/pnas.1116889109
   PubMed Web of Science ®Google Scholar
• Bi P, Shan T, Liu W, et al. Inhibition of notch signaling promotes browning of white adipose tissue and ameliorates obesity. Nat Med. 2014;20(8):911–918. doi: 10.1038/nm.3615
   PubMed Web of Science ®Google Scholar
• Farrar JS, Lownik JC, Way GW, et al. Identification of the transgene insertion site for an adipocyte-specific adiponectin-cre model and characterization of the functional consequences. Adipocyte. 2021;10(1):91–100. doi: 10.1080/21623945.2021.1880083
   PubMed Web of Science ®Google Scholar
• Palaga T, Buranaruk C, Rengpipat S, et al. Notch signaling is activated by TLR stimulation and regulates macrophage functions. Eur J Immunol. 2008;38(1):174–183. doi: 10.1002/eji.200636999
   PubMed Web of Science ®Google Scholar
• Huh JY, Kim JI, Park YJ, et al. A novel function of adipocytes in lipid antigen presentation to iNKT cells. Mol Cell Biol. 2013;33(2):328–339. doi: 10.1128/MCB.00552-12
   PubMed Web of Science ®Google Scholar
• Kir S, White JP, Kleiner S, et al. Tumour-derived PTH-related protein triggers adipose tissue browning and cancer cachexia. Nature. 2014;513(7516):100–104. doi: 10.1038/nature13528
   PubMed Web of Science ®Google Scholar
• Sikora-Skrabaka M, Walkiewicz KW, Nowakowska-Zajdel E, et al. ADAM10 and ADAM17 as biomarkers linked to inflammation, metabolic disorders and colorectal cancer. Curr Issues Mol Biol. 2022;44(10):4517–4527. doi: 10.3390/cimb44100309
   PubMed Web of Science ®Google Scholar
• Hildebrandt X, Ibrahim M, Peltzer N. Cell death and inflammation during obesity: “Know my methods, WAT(son)”. Cell Death Differ. 2023;30(2):279–292.
   PubMed Web of Science ®Google Scholar
• Reilly SM, Saltiel AR. Adapting to obesity with adipose tissue inflammation. Nat Rev Endocrinol. 2017;13(11):633–643. doi: 10.1038/nrendo.2017.90
   PubMed Web of Science ®Google Scholar
• Spencer M, Yao-Borengasser A, Unal R, et al. Adipose tissue macrophages in insulin-resistant subjects are associated with collagen VI and fibrosis and demonstrate alternative activation. Am J Physiol Endocrinol Metab. 2010;299(6):E1016–27. doi: 10.1152/ajpendo.00329.2010
   PubMed Web of Science ®Google Scholar
• Wu H, Ballantyne CM. Metabolic inflammation and insulin resistance in obesity. Circ Res. 2020;126(11):1549–1564. doi: 10.1161/CIRCRESAHA.119.315896
   PubMed Web of Science ®Google Scholar
• Menghini R, Fiorentino L, Casagrande V, et al. The role of ADAM17 in metabolic inflammation. Atherosclerosis. 2013;228(1):12–17. doi: 10.1016/j.atherosclerosis.2013.01.024
   PubMed Web of Science ®Google Scholar
• Matthews J, Villescas S, Herat L, et al. Implications of ADAM17 activation for hyperglycaemia, obesity and type 2 diabetes. Biosci Rep. 2021;41(5). doi: 10.1042/BSR20210029
   PubMed Web of Science ®Google Scholar
• Fruhbeck G, Catalan V, Rodriguez A, et al. Adiponectin-leptin ratio is a functional biomarker of adipose tissue inflammation. Nutrients. 2019;11(2):454. doi: 10.3390/nu11020454
   PubMed Web of Science ®Google Scholar
• Gordon S, Taylor PR. Monocyte and macrophage heterogeneity. Nat Rev Immunol. 2005;5(12):953–964. doi: 10.1038/nri1733
   PubMed Web of Science ®Google Scholar
• Villarroya F, Cereijo R, Villarroya J, et al. Toward an understanding of how immune cells control brown and beige adipobiology. Cell Metab. 2018;27(5):954–961. doi: 10.1016/j.cmet.2018.04.006
   PubMed Web of Science ®Google Scholar
• Fujisaka S, Usui I, Bukhari A, et al. Regulatory mechanisms for adipose tissue M1 and M2 macrophages in diet-induced obese mice. Diabetes. 2009;58(11):2574–2582. doi: 10.2337/db08-1475
   PubMed Web of Science ®Google Scholar
• Wellen KE, Hotamisligil GS. Inflammation, stress, and diabetes. J Clin Invest. 2005;115(5):1111–1119. doi: 10.1172/JCI25102
   PubMed Web of Science ®Google Scholar
• Olefsky JM, Glass CK. Macrophages, inflammation, and insulin resistance. Annu Rev Physiol. 2010;72(1):219–246. doi: 10.1146/annurev-physiol-021909-135846
   PubMed Web of Science ®Google Scholar
• Donath MY, Shoelson SE. Type 2 diabetes as an inflammatory disease. Nat Rev Immunol. 2011;11(2):98–107. doi: 10.1038/nri2925
   PubMed Web of Science ®Google Scholar
• Silva HM, Bafica A, Rodrigues-Luiz GF, et al. Vasculature-associated fat macrophages readily adapt to inflammatory and metabolic challenges. J Exp Med. 2019;216(4):786–806. doi: 10.1084/jem.20181049
   PubMed Web of Science ®Google Scholar
• Shaul ME, Bennett G, Strissel KJ, et al. M2-like remodeling phenotypes of CD11c+ adipose tissue macrophages during high-fat diet–induced obesity in mice. Diabetes. 2010;59(5):1171–1181. doi: 10.2337/db09-1402
   PubMed Web of Science ®Google Scholar
• Tsatsanis C, Zacharioudaki V, Androulidaki A, et al. Adiponectin induces TNF-α and IL-6 in macrophages and promotes tolerance to itself and other pro-inflammatory stimuli. Biochem Biophys Res Commun. 2005;335(4):1254–1263. doi: 10.1016/j.bbrc.2005.07.197
   PubMed Web of Science ®Google Scholar
• Foldi J, Chung AY, Xu H, et al. Autoamplification of notch signaling in macrophages by TLR-induced and RBP-J-dependent induction of Jagged1. J Immunol. 2010;185(9):5023–5031. doi: 10.4049/jimmunol.1001544
   PubMed Web of Science ®Google Scholar
• Boonyatecha N, Sangphech N, Wongchana W, et al. Involvement of notch signaling pathway in regulating IL-12 expression via c-rel in activated macrophages. Mol Immunol. 2012;51(3–4):255–262. doi: 10.1016/j.molimm.2012.03.017
   PubMed Web of Science ®Google Scholar
• Mills EL, Harmon C, Jedrychowski MP, et al. Cysteine 253 of UCP1 regulates energy expenditure and sex-dependent adipose tissue inflammation. Cell Metab. 2022;34(1):140–57 e8. doi: 10.1016/j.cmet.2021.11.003
   PubMed Web of Science ®Google Scholar
• Nishimura S, Manabe I, Nagasaki M, et al. CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nat Med. 2009;15(8):914–920. doi: 10.1038/nm.1964
   PubMed Web of Science ®Google Scholar
• Ni B, Chen S, Ryan KA, et al. Selective adipocyte loss of angiopoietin-2 prompts female-specific obesity and metabolic syndrome. Mol Metab. 2022;65:101588. doi: 10.1016/j.molmet.2022.101588
   PubMed Web of Science ®Google Scholar
• Moysidou M, Karaliota S, Kodela E, et al. CD8+ T cells in beige adipogenesis and energy homeostasis. JCI Insight. 2018;3(5). doi: 10.1172/jci.insight.95456
   PubMed Web of Science ®Google Scholar
• Lownik JC, Farrar JS, Pearce JV, et al. Adipocyte ADAM17 plays a limited role in metabolic inflammation. Adipocyte. 2020;9(1):509–522. doi: 10.1080/21623945.2020.1814544
   PubMed Web of Science ®Google Scholar
• Hiragun A, Sato M, Mitsui H. Preadipocyte differentiation in vitro: identification of a highly active adipogenic agent. J Cell Physiol. 1988;134(1):124–130. doi: 10.1002/jcp.1041340115
   PubMed Web of Science ®Google Scholar
• Sandouk T, Reda D, Hofmann C. Antidiabetic agent pioglitazone enhances adipocyte differentiation of 3T3-F442A cells. Am J Physiol. 1993;264(6 Pt 1):C1600–8. doi: 10.1152/ajpcell.1993.264.6.C1600
   PubMedGoogle Scholar
• Yki-Jarvinen H. Thiazolidinediones. N Engl J Med. 2004;351(11):1106–1118. doi: 10.1056/NEJMra041001
   PubMed Web of Science ®Google Scholar
• Tang W, Zeve D, Seo J, et al. Thiazolidinediones regulate adipose lineage dynamics. Cell Metab. 2011;14(1):116–122. doi: 10.1016/j.cmet.2011.05.012
   PubMed Web of Science ®Google Scholar